Income statement
USD
Annual
| Metric | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|
| Revenue | 141K | 150K | 68K | 54K |
| Gross Profit | 137K | 81K | -30K | 10K |
| Operating Income | -2M | -2M | -3M | -2M |
| EBITDA | -2M | -2M | -2M | -2M |
| Net Income | -2M | -2M | -3M | -2M |
| EPS (Diluted) | — | — | — | — |
Financial Services
Live Price
Offline$0.0098
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SpectrumDNA, Inc. (SPXA) is a Financial Services stock with listed on OTC. The stock last traded around $0.01 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of -5.7%, EPS growth of +41.5%, a dividend yield of 0.0%. What stands out right now is revenue -5.7%, EPS +41.5%, free cash flow -76.2% with operating margin -1362.4% and ROIC -482.1%. Valuation sits in the middle of the pack at price/sales 4.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SPXA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SPXA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SPXA Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SPXA and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$54.0K
-20.4% YoY
FY Net Income
-$1.8M
+28.4% YoY
Free Cash Flow
-$1.0M
+20.0% YoY
Revenue Growth
-5.7%
EPS Growth
+41.5%
Gross Margin
97.1%
Net Margin
-1392.5%
Income statement
USD
| Metric | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|
| Revenue | 141K | 150K | 68K | 54K |
| Gross Profit | 137K | 81K | -30K | 10K |
| Operating Income | -2M | -2M | -3M | -2M |
| EBITDA | -2M | -2M | -2M | -2M |
| Net Income | -2M | -2M | -3M | -2M |
| EPS (Diluted) | — | — | — | — |
Balance sheet
USD
| Metric | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|
| Cash & Equivalents | 196K | 10K | 548K | 2M |
| Total Assets | 534K | 52K | 711K | 2M |
| Total Liabilities | 151K | 458K | 46K | 68K |
| Shareholder Equity | 383K | -406K | 665K | 2M |
| Total Debt | 16K | 121K | 0 | 0 |
| Net Debt | -180K | 110K | -548K | -2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1M
+19.5% YoY
Capital Expenditures
6K
+58.9% YoY
Free Cash Flow
1M
+20.0% YoY
Key ratios
Gross Margin
97.1%
Operating Margin
-1362.4%
Net Margin
-1392.5%
ROE
17454.1%
Debt / Equity
0.04x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.